NR1D1 Inhibition Enhances Autophagy and Mitophagy in Alzheimer's Disease Models

Shiqi Zhang, Zhangming Niu, Alexander Anisimov, Fang Shi, Shibing Deng, Xianglu Xiao, Shuqin Cao, Junping Pan, Heling Wang, Mariá José Lagartos-Donate, Nihal Gullu Bozbas, P. Wang, Ruixue Ai, Yan Li, Guang Yang, Sofie Lautrup, Evandro Fei FangAging 2025 · DOI

This study, recently published in Aging and Disease, explores a novel therapeutic target for Alzheimer’s Disease (AD) by focusing on the cell's internal "garbage disposal" system. Researchers demonstrate that inhibiting the nuclear receptor NR1D1 (also known as Rev-erbα) jumpstarts autophagy and mitophagy, leading to improved cognitive function and extended lifespan in animal models of AD.

TL;DR

Researchers have identified NR1D1 as a "brake" on the cellular processes that clear out toxic proteins and damaged mitochondria in Alzheimer’s Disease. By inhibiting NR1D1, they successfully restored these cleaning mechanisms, leading to improved memory and significantly longer lifespans in C. elegans and mouse models.

What Problem Does This Paper Address?

Alzheimer’s Disease is characterized by the accumulation of toxic protein aggregates—specifically extracellular beta-amyloid (Aβ) plaques and intracellular Tau tangles. Under healthy conditions, the body uses autophagy (general cellular recycling) and mitophagy (targeted recycling of damaged mitochondria) to clear these "clogs."

In AD, these recycling pathways are often impaired, leading to a buildup of cellular debris and dysfunctional "power plants" (mitochondria), which ultimately causes neuronal death. The authors investigated whether NR1D1, a protein involved in circadian rhythms and metabolism, could be modulated to restart these stalled recycling systems.

Methods

The study employed a multi-species approach, moving from cell cultures to simple organisms and finally to complex mammalian models:

  • Cellular Models: The team used HeLa and U2OS cell lines. They employed siRNA knockdown to reduce NR1D1 levels and used sophisticated fluorescent reporters (like mt-Keima and ptf-LC3B) to visualize the actual flow (flux) of autophagy and mitophagy in real-time.
  • C. elegans (Roundworms): They targeted the worm ortholog of NR1D1, called nhr-85, using RNA interference (RNAi). They measured neuronal mitophagy using a mt-Rosella biosensor and conducted associative memory assays (chemotaxis) and lifespan studies.
  • 5xFAD Mice: This is a standard mouse model of AD. The researchers used Adeno-associated virus (AAV) to deliver shRNA directly into the hippocampus to knock down Nr1d1 and then analyzed protein expression via Western Blotting.
  • Bioinformatics: They analyzed the ROSMAP dataset to correlate NR1D1 expression levels with AD progression in human patients.

Datasets

  • ROSMAP (Religious Orders Study and Memory and Aging Project): A large-scale human dataset used to analyze transcriptional changes in the prefrontal cortex of AD patients.
  • STRING Database: Used for computational prediction of protein-protein interactions.
  • GSE248721: A public transcriptomic dataset of NR1D1 knockout in U2OS cells.

Key Insights and Ideas

  • NR1D1 as an AD Biomarker: Analysis of human brain data (ROSMAP) showed that NR1D1 expression actually increases as AD progresses, particularly in excitatory neurons. This suggests that the "brake" on autophagy gets tighter as the disease worsens.
  • The SIRT1/Cathepsin B Axis: The study identified a specific molecular pathway. Inhibiting NR1D1 activates SIRT1 (a well-known longevity-related protein) and increases levels of Cathepsin B (a lysosomal enzyme). Together, these proteins facilitate the breakdown of cellular waste.
  • Mitophagy Restoration: Beyond just clearing proteins, NR1D1 inhibition helped maintain mitochondrial health. In the presence of mitochondrial stressors (like FCCP), NR1D1 knockdown prevented the collapse of mitochondrial membrane potential and improved mitochondrial morphology.

Key Results

  • Lifespan Extension: In C. elegans, knocking down the NR1D1 ortholog extended the median lifespan by 29.4% in wild-type worms and 12.5% in AD-model worms.
  • Memory Improvement: AD-model worms showed a significant restoration of associative memory following nhr-85 depletion.
  • Autophagy Markers in Mice: In 5xFAD mice, a 50% reduction in NR1D1 successfully restored the expression of LC3B-II, a critical marker of autophagosome formation that is typically depleted in AD.
  • Cellular Flux: In human cell lines, NR1D1 depletion significantly increased the number of autophagolysosomes, confirming that the entire recycling process—from engulfing waste to digesting it—was enhanced.

Limitations and Future Work

The authors note a few critical caveats:

  1. The Aβ Paradox: While autophagy markers improved and memory was restored, the levels of soluble Aβ did not significantly change in the mouse models. This suggests that the cognitive benefits might stem from improved neuronal resilience or mitochondrial health rather than a simple reduction in plaque-forming proteins.
  2. The Double-Edged Sword: Excessive autophagy can lead to cell death. The researchers observed decreased cell viability in some in vitro models when NR1D1 was knocked down, suggesting that therapeutic dosing would need to be precisely calibrated.
  3. Circadian Concerns: Since NR1D1 is a core component of the circadian clock, long-term systemic inhibition could potentially disrupt sleep-wake cycles or metabolic health. Future studies will need to explore brain-specific or time-targeted delivery of NR1D1 inhibitors.

Summary updated

Abstract

Alzheimer's disease (AD) is marked by extracellular beta-amyloid (Aβ) plaques and intracellular Tau tangles, leading to progressive cognitive decline and neuronal dysfunction. Impaired autophagy, a process by which a cell breaks down and destroys damaged or abnormal proteins and other substances, contributes to AD progression. This study investigated Nuclear Receptor Subfamily 1 Group D Member 1 (NR1D1) as a potential therapeutic target for modulating autophagy. We show that NR1D1 depletion significantly enhances autophagic flux and mitophagy in human cell lines as well as wildtype and AD Caenorhabditis elegans (C. elegans) models. Our findings revealed that NR1D1 knockdown increased autophagy markers and activated the proteins Sirtuin 1 (SIRT1) and CTSB cathepsin B (Cathepsin B), both linked to autophagy function. In 5 familial AD mutations (5xFAD) mice, Nr1d1 knockdown restored the expression level of autophagy markers. C. elegans experiments revealed that depletion of the worm ortholog of NR1D1, nhr-85, improved neuronal mitophagy, enhanced associative memory in amyloid-β models, and extended lifespan. These findings suggest NR1D1 as a promising therapeutic target for improving cellular autophagy mechanisms in AD.
BibTeX
@inproceedings{zhang2025nr,
  author = {Shiqi Zhang and Zhangming Niu and Alexander Anisimov and Fang Shi and Shibing Deng and Xianglu Xiao and Shuqin Cao and Junping Pan and Heling Wang and Mariá José Lagartos-Donate and Nihal Gullu Bozbas and P. Wang and Ruixue Ai and Yan Li and Guang Yang and Sofie Lautrup and Evandro Fei Fang},
  title = {{NR1D1 Inhibition Enhances Autophagy and Mitophagy in Alzheimer's Disease Models}},
  booktitle = {Aging},
  year = {2025},
  doi = {10.14336/ad.2024.1654},
}
Figure